INTRODUCTION
Collagen XIV (COLXIV) belongs to a subfamily of collagens called FibrillarAssociated Collagens with Interrupted Triple helices (FACIT). COLXIV is a homotrimer with a trident-like structure (1) . In the homotrimer, the trimerization of the collagenous domains forms a stem from which three long arms formed by the non-collagenous domains extend. COLXIV is found in many connective tissues, such as skin, tendon and cornea (2) (3) (4) (5) (6) . Electron microscopy studies have shown that COLXIV localizes in vivo to the surface of collagen I fibrils (4, 7, 8) . In embryonic chick tendon, it is expressed when collagen fibrils elongate and ceases to be expressed when fibrils thicken (8) suggesting that COLXIV regulates collagen fibril assembly.
Analysis of Col14a1-null mice further confirmed a role of COLXIV in early stages of collagen fibrillogenesis (9) . However, COLXIV has been also shown to bind to a wide variety of cells (10) (11) (12) , suggesting a possible role in cell function.
Here, we show that zebrafish COLXIV-A is transiently expressed in several undifferentiated epithelia, and incorporated into the underlying BM. COLXIV is structurally closely related to COLXII, and these two collagens are often coexpressed (5, 6, 13) . Using zebrafish anti-COLXII (14) and newly prepared anti-COLXIV-A antibodies, we found marked differences in the expression pattern of these two collagens: COLXII was expressed in connective tissues (14) , whereas COLXIV-A was expressed in epithelia. However, their expression overlapped in the basement membrane, and in particular the epidermal-dermal basement membrane. Morpholino knock-down of COLXIV-A demonstrated a crucial role of this protein in the proper formation of the epidermal-dermal basement membrane, and in the cohesion of the epidermis and the subjacent dermis. Our findings are in line with recent work showing that COLXII and COLXIV localize to anchoring plaques (e.g. protein complexes involved in the attachment of the basement membrane to the skin) in human skin (13) . Taken together, we demonstrate that (1) COLXIV-A is embryonically regulated; (2) collagens XII and XIV may have distinct spatio-temporal expression patterns during development; (3) at early developmental stages, COLXIV-A has a role in undifferentiated epithelia, and in the formation of the basement membrane.
EXPERIMENTAL PROCEDURES

Cloning of a partial col14a1a cDNA
We have previously reported the cloning of a partial cDNA for col14a1a (AM941492, (14) ). This cDNA was used for the design of primers, in situ probes and antibodies specific for col14a1a (see below). It should be noted that the sequence cloned by us is not identical to the hypothetical col14a1a mRNA sequence available in the NCBI database (XM_001922011; deduced from genomic sequence). XM_001922011 encodes a 5 amino acid insert missing in AM941492 (VSILG), and 7 amino acids differ in the two sequences. Furthermore, AM941492 encodes a 19 amino acid long spacer (GWTTEFPTTIPTTTPI) separating the 5th and 6th FNIII domain that is missing in XM_001922011. This discrepancy could not be simply explained by alternative splicing, since the sequence encoding this spacer was also not found in the genomic reference sequence database of NCBI. However, we believe that our cDNA (AM941492) is correct for the following reasons: (1) tetrapod COLXIV α1 chains have also a spacer between the 5 th and the 6 th FNIII domains; (2) we obtained the same cDNA sequence with two independent RTPCRs.
Recombinant expression of fibronectin type III domains (FNIII) and preparation and characterization of polyclonal antibodies specific for zebrafish COLXIV-A
Polyclonal antibodies specific for zebrafish COLXIV-A were prepared as described previously (14) . Briefly, clone AM941492 was subcloned into a bacterial expression vector, and the His-tagged fusion protein was affinity purified with a Ni-sepharose column. After removal of the His-tag, the purified protein was used to immunize a rabbit and a guinea pig. The polyclonal antibodies obtained after sacrificing the animals were affinity-purified using a column of antigen coupled to sepharose. To test the specificity of the affinity purified antibodies, an ELISA assay was performed as described previously (14) . Furthermore, the specificity of the antibodies was confirmed with a preincubation assay. Purified polyclonal guinea pig anti-zebrafish collagen-XIV antibody diluted 1:250 in blocking solution was incubated with 8 µg purified recombinant COLXIV-FNIII or 8 µg or 40 µg of COLXII-FNIII protein overnight at 4°C.
Subsequently, whole mount immunofluorescence staining of 48 hpf embryos was performed as described below. The immunofluorescence signal was efficiently extinguished by pre-incubation with COLXIV-FNIII domains, but not COLXII-FNIII domains.
Fish maintenance
Fish were maintained and eggs were obtained essentially as previously described by Westerfield, 2007 (15) . Embryos were staged according to hours post-fertilization (hpf) at 28.5°C and according to morphological criteria (16) . Different wild type strains (AB, AB/Tu, AB/TL and fish from a pet shop) were used for expression pattern analysis. No differences in by guest on November 19, 2017 http://www.jbc.org/ Downloaded from collagen expression between the different strains were observed.
Western blot analysis on whole embryos
Protein extracts from whole embryos at 24-120 hpf were prepared using NP-40 lysis buffer (1 % (v/v) NP-40, 150 mM NaCl, 50 mM Hepes pH 7.4, 5 mM EDTA, 10 % (v/v) glycerol and complete protease inhibitor cocktail (Calbiochem)). After homogenization using a pellet pestle and centrifugation (13000 g, 15 min, 4°C, protein concentration of supernatant was determined by BCA protein assay (Pierce) and equal amounts of proteins (20-25 µg) were loaded on SDS-polyacrylamide gel after heating for 5 min at 100°C. For the study of COLXIV-A electrophoretic pattern in SDS-PAGE, the electrophoresis sample buffer contained 90 mM Tris-HCl, pH 6.8, 8.0, 9.0 or 10.5 as indicated, 10 % (v/v) glycerol, 5 % (w/v) SDS, 0.02 % (w/v) bromophenol blue.
Collagenase digestion of the α1 chain of zebrafish collagen XIV-A Collagenase digestion was performed as described previously (14) . Protein extracts from whole embryos at 24 hpf were prepared using NP-40 lysis buffer (1 % (v/v) NP-40, 150 mM NaCl, 50 mM Hepes pH 7.4, 5 mM EDTA, 10 % (v/v) glycerol and complete protease inhibitor cocktail (Calbiochem)). After homogenization using a pellet pestle and centrifugation (13000 g, 15 min, 4°C), protein concentration of the supernatant was determined and 30 µg of proteins were incubated for 2 h at 4 or 37C° with or without 200 U/ml collagenase (CLSPA, Worthington biochemical corporation) in enzymatic reaction buffer containing 5 mM CaCl 2 and 1 mM AEBSF. The enzymatic reaction product was analyzed by Western blot using the affinity purified polyclonal rabbit antizebrafish COLXIV-A antibodies (dilution 1:2000), followed by incubation with horseradish peroxidase conjugated goat anti-rabbit IgG antibodies (Bio-Rad #170-6515, dilution 1:10000) and revelation with a chemiluminescence substrate kit (Immun-Star WesternC Chemiluminescent Kit, Bio-Rad #170-5070).
RT-PCR
Total RNA was extracted from 20 embryos at various time points by using Nucleospin® RNA II kit (Macherey-Nagel) according to the protocol for animal tissues. First-strand cDNA synthesis was performed using M-MLV Reverse Transcriptase (Promega), followed by amplification of desired cDNA by PCR with Taq DNA polymerase with ThermoPol buffer (BioLabs).
Whole mount in situ hybridization
For the preparation of two different col14a1a specific probes, the partial cDNA AM941493 was digested with NcoI and the resulting 686 bp and 406 bp fragments were subcloned and were used to prepare digoxigenin labeled anti-sense probes (Roche). Whole mount in situ hybridization was performed as previously described (17) . 48 and 72 hpf embryos were pretreated with PTU to suppress pigmentation as described previously (14) .
Whole mount immunofluorescence staining
Whole mount immunofluorescence staining was performed as described previously (14) . The following primary and secondary antibodies were used at the indicated dilutions: affinity purified polyclonal guinea pig antibodies specific for zebrafish COLXIV-A, 1:250; affinity purified rabbit polyclonal antibodies specific for zebrafish COLXIV-A, 1:500; affinity purified rabbit polyclonal antibodies specific for zebrafish COLXII, 1:400 or 1:250; rabbit antilaminin antibodies (Sigma L9393 -chain specificity unknown), Histology and transmission electron microscopy Zebrafish embryos and larvae were processed as previously described (18) . Whole embryos and larvae were sacrificed by incubation with excess of tricaine and fixed overnight in 1.5 % (v/v) glutaraldehyde and 1.5 % (v/v) paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) at 4°C followed by washing in 0.1 M cacodylate buffer, 10 % (w/v) sucrose. Samples were then post-fixed in 1 % (v/v) osmium tetroxide for 1 h at room temperature, subsequently dehydrated in a graded series of ethanol, and embedded in epoxy resin. Thin sections were stained with Methylene blue/azur II and observed with a light microscope (Leica) equipped with a digital camera (Nikon). Ultra thin sections were contrasted with uranyl acetate and lead citrate, and observed with a Philips CM120 electron microscope at the "Centre Technique des Microstructures", University of Lyon 1 equipped with a digital CCD camera (Gatan).
Statistical analysis
Results are given as the mean ± s.e.m. The significance of differences between mean values was evaluated by Student t test (p<0.05, *; p<0.01, **; p<0.001, ***).
RESULTS
Zebrafish has duplicate col14a1 genes
In a search for zebrafish col14a1, we found two sequences with high homology to the chicken col14a1 mRNA in the NCBI database: XM_001922011 and XM_003200499. These are mRNAs predicted on the basis of genomic sequences that are localized on chromosome 16 (XM_001922011) and chromosome 19 (XM_003200499), respectively. We will refer to these paralogs as col14a1a (XM_001922011) and col14a1b (XM_003200499). Both paralogs showed higher homology to tetrapod α1 (XIV) than to tetrapod α1 (XII) chains, confirming that they encode α1 (XIV) chains. It should be noted that zebrafish has also two col12a1 paralogs. We will refer to these as col12a1a (XM_002665259) and col12a1b (XM_686312). Our previously published col12a1 in situ probes are specific for col12a1a (14) . Since the paralogs show high homology in the domains recognized by the antibodies (70 % overall and 90 % for the first fibronectin type III domain) our antibodies may recognize both paralogs. Since the specificity of the antibodies is unclear, we will refer simply to COLXII when describing data obtained with anti-COLXII antibodies.
Conserved domain organization of zebrafish and tetrapod α1 (XIV) chains Hypothetical protein sequences of the zebrafish α1 (XIV) chains are available in the NCBI database:
XP_001922046, COLXIV-A; XP_003200547, COLXIV-B. These protein sequences are deduced from genomic sequences.
We used these sequences to analyze the domain organization of the zebrafish α1 (XIV) chains. For our analysis, we used the scanprosite tool (Expasy, http://www.expasy.ch/tools/scanprosite/), combined with manual screening.
The N-terminus of COLXIV-A consists of eight fibronectin type III repeats (FNIII) alternating with two von Willebrand Factor A (vWA) domains, and a Thrombospondin N-terminal like domain (TSPN). The C-terminus consists of 2 short non-collagenous sequences (NC1 and NC2) and 2 collagenous domains (COL1 and COL2) ( Fig. 1A and B) . This domain organization is identical to the domain organization of tetrapod COLXIV (19) . In contrast, COLXIV-B is Nterminally truncated: it lacks the first vWA domain, and the first three FNIII domains (see Fig. 1A ). However, it is very likely that the col14a1b sequence is still incomplete, since it lacks an N-terminal signal peptide, which is a feature of all secreted ECM proteins, including tetrapod COLXIV and zebrafish COLXIV-A. Unfortunately, we were so far unable to find the missing sequence in databases.
Both zebrafish α1 (XIV) chains have the typical FACIT signature, e.g. two short collagenous domains alternating with two non-collagenous domains at the C-terminus. Furthermore, as is the case in all FACITs, the COL1 domain has two imperfections -e.g., an interruption in the GXX triplet repeats -and a conserved CXXXXC motif is found at the NC1-COL1 junction ( Fig. 1B and  C) . In addition, as described for tetrapod COLXII and COLXIV, the COL2 domain has also an imperfection (Fig. 1B) . The triple helical imperfections and the cysteine motif are highly RT-PCR showed that col14a1a and col14a1b are differentially expressed; col14a1a was first detected at 18 hpf and peaked between 18 and 24 hpf ( Fig. 2A) . In contrast, col14a1b mRNA expression started later (32 hpf), and continued to be expressed at high levels at late developmental stages (48 -120 hpf). The col12a1 paralogs also showed a differential expression pattern. col12a1a was detected at all developmental stages analyzed, including very early embryogenesis (2.5 hpf), indicating that it is a maternal transcript, whereas col12a1b was first detected at 18 hpf ( Fig. 2A) .
In other species, col14a1 expression has been mainly analyzed at late developmental stages. The fact that col14a1a expression peaked at early developmental stages (18s -24 hpf) suggested that an analysis of its expression pattern might uncover previously unreported functions of col14a1 in early embryogenesis. Also, col14a1a showed higher homology to chicken col14a1 than col14a1b (60% identity, 73% conserved vs 48% identity, 60% conserved on the protein level). Finally, human COL14A1 gene has been previously mapped to chromosome 8q23 (20) . Using ensembl for in silico chromosome mapping analysis, we demonstrate that the orthologous gene triplet DEPTOR/COL14A1/MRPL13 observed in the Homo sapiens genome is conserved (deptor/col14a1a/mrpl13) in chromosome 16 of danio rerio genome. No conserved synteny was observed in the chromosomal region containing col14a1b. For all these reasons, we decided to focus our subsequent expression pattern analysis on col14a1a.
col14a1a expression is developmentally regulated
In situ hybridization confirmed the absence of col14a1a expression before somitogenesis (data not shown) as previously reported by (21) with cb542 probe. At the 18-somite stage, col14a1a transcripts were detected in neural and epidermal/peridermal tissues. Neurectodermal structures include telencephalic regions, the ear placode and a narrow band within the brain (Fig.   2Bb , arrow) that likely corresponds to the midbrain-hindbrain boundary (MHB) since signal was clearly detected in the MHB at 24 hpf (Fig. 2Bd) . Ectodermal structures include parts of the epidermis ( Fig. 2Ba and b) and the nascent fin fold (Fig. 2Bc) . At 24 hpf, expression in the telencephalon and the ear placode is strongly reduced and expression appeared in the nasal placode, the MHB and in pharyngeal pouches two and three. A small col14a1a-positive area was observed in the roof of the forebrain, which corresponds to the pineal organ location (Fig.  2Bd, arrowhead) . Furthermore, col14a1a expression persisted throughout the skin and the developing fin fold ( Fig. 2Be and f) . At 48 hpf, col14a1a expression in the skin could not be distinguished from background staining (Fig.  2Bh ). In the head, expression was restricted to the otic anterior macula and the pharyngeal arch endoderm ( Fig. 2Bg and h ). In addition, a strong signal was observed in the apical fin fold of the pectoral fin bud (Fig. 2Bi) . At 72 hpf, col14a1 mRNA was detected in the gut (Fig. 2Bj ) and expression persisted in the anterior macula ( Fig.  2Bk ), whereas expression in the fin fold had ceased (data not shown), and only a very weak signal was detected in the apical fin fold of the pectoral fin bud (Fig. 2Bl) .
Characterization of zebrafish COLXIV-A protein
We prepared polyclonal antibodies against zebrafish COLXIV-A, and used them to characterize the zebrafish α1 (XIV-A) chain. In a Western blot with protein extracts from 24 hpf zebrafish embryos, a band of ∼ 200 kDa was detected, corresponding to the expected molecular weight of COLXIV-A. Furthermore, this band was, as expected, collagenase sensitive. COLXIV-A consists predominantly of noncollagenous domains and collagenase treatment results therefore only in a small shift of the band when analyzed by SDS-PAGE (Fig. 3A) . Interestingly, COLXIV-A is perfectly soluble in the NP-40 lysis buffer since no protein was detected in the insoluble fraction by Western blot (data not shown). A second band (significantly above 200 kDa) was also detected in addition to the ∼200 kDa band (Fig.3A) . Such an electrophoretic pattern has been previously described for both tetrapod COLXII and COLXIV, and it was found that the upper band corresponds to a disulfide bonded dimer of the α1 chain that is resistant to by guest on November 19, 2017 http://www.jbc.org/ Downloaded from β−mercaptoethanol-mediated reduction in standard conditions (22, 23) . Here, we show that alkalinisation of the sample buffer from pH6.8 to pH8 resulted in a decrease of the upper band intensity with a concomitant increase of the ∼200 kDa band intensity (Fig. 3B ). This strongly suggests that the upper band corresponds to a dimer of zebrafish α1(XIV) chains. A further increase in pH to pH9 and 10.5 allowed complete dissociation of dimer into monomer as assessed by the disappearance of the upper band. These results show that COLXIV resolution by SDS-PAGE reveals a ∼200 kDa band corresponding to monomer of α1(XIV) chain and an upper band corresponding to dimer whose dissociation by β-mercaptoethanol is pH sensitive. It should be noted that the bands recognized by anti-COLXIV-A antibodies were efficiently extinguished by morpholinos directed against COLXIV-A, confirming the specificity of the antibodies, and excluding the possibility of cross-reaction with COLXIV-B (Fig.7A ).
COLXIV-A protein expression peaks between 24 and 48 hpf
Protein expression was analyzed on total protein extracts of 24 to 120 hpf embryos ( Fig. 3C and  D) . It should be noted that it did not make a difference whether deyolked or undeyolked embryos were used for the protein expression analysis. Because the various loading controls commonly used in the literature (GAPDH, β-actin, tubulin or acetylated tubulin) varied significantly during the early stages of development (between 24 and 48 hpf), we quantified the protein expression of both collagens by comparing them with acetylated tubulin protein amounts (Fig. 3D) , as well as β-actin expression (data not shown). Similar results were observed with both control proteins. We thus demonstrate that COLXIV-A is highly expressed very early during zebrafish development (at 24 and 48 hpf) and this strong expression drastically and significantly decreases from 72 hpf until 120 hpf. In contrast, COLXII protein expression continuously increased from 24 to 120 hpf.
COLXIV-A is detected in undifferentiated epithelia and subjacent BMs
Immunofluorescence staining of whole embryos was then performed to determine the location of COLXIV-A during embryonic development. At 24 hpf, COLXIV-A was expressed in several epithelia (Fig. 4) . In agreement with the in situ hybridization data, COLXIV-A was detected in three cranial placodes, e.g. the nasal/olfactory placode, the lens and the ear/otic placode (Fig.  4A ). COLXIV-A was also detected in the BM encasing the placodes, and in the meninges (Fig.  4A and B) . Interestingly, however, COLXIV-A was not only expressed in basal placodal cellswhich synthesize the BM components -but throughout the entire placodal tissue (Fig. 4A) . The placodes originate from the ectoderm and retain at 24 hpf still characteristics of the surface epithelium (24) (25) (26) (27) . This epithelial expression pattern contrasted strikingly with the expression pattern of COLXII, which was detected in the connective tissue surrounding the placodes ( Fig.  4B and (14)). However, COLXII and COLXIV-A staining coincided in the basement membrane (Fig. 4B ). This is in agreement with our previous work that showed that COLXII is present in the immediate vicinity of the basement membrane (the basement membrane zone, a junctional zone with protein complexes that link the BM to the subjacent connective tissue) (14) . At 24 hpf, COLXIV-A was also detected in basal epidermal cells, and the epidermal-dermal BM (Fig. 4C) . Interestingly, within the basal epidermal cells, COLXIV-A did not show a polarized distribution, but could be detected both at the apical and basal poles (Fig. 4C) . In addition to these ectodermal derived epithelia, COLXIV-A was also detected in epithelia of endodermal origin. At 24 hpf, COLXIV-A was detected in the 2 nd and 3 rd pharyngeal pouch (identified by the marker Zn8, Fig.4D ), and at 72 hpf, it was detected in the gut (Fig. 4E) .
COLXIV-A expression ceases in differentiated epithelia, but persists in BMs At 48 and 72 hpf, when the differentiation of organs and tissues is well advanced in zebrafish, COLXIV-A was not detected in epithelia anymore. Since the expression pattern of COLXIV-A was essentially the same at 48 and 72 hpf, we will describe here only the expression pattern at 72 hpf. At 72 hpf, COLXIV-A could not be detected anymore in the olfactory placode (Fig. 5A) , the lens (Fig. 5B) , basal epidermal cells (Fig. 5C ) and the gill endoderm (Fig. 5D ). In the otic placode, COLXIV-A became restricted to the anterior macula, which is one of three sensory patches involved in the detection of by guest on November 19, 2017 http://www.jbc.org/ Downloaded from rotation and acceleration in teleost. Interestingly, COLXIV-A was detected within the sensory neurons of the macula (Fig. 5E) . The only other epithelium in which COLXIV-A was detected at 72 hpf was the gut (Fig. 4E) . However, the gut is the last organ to form, and at 72 hpf, the gut epithelium has not yet started to differentiate (28) , corroborating that COLXIV-A is specifically expressed in undifferentiated epithelia COLXIV-A is expressed in the median and apical fin fold The median fin fold (MFF) and the apical fold of the pectoral fin bud are epithelial folds with a core of connective tissue. It is thought that the outgrowth of the fin folds involves cell shape changes of a tip cell, as well as proliferation (29, 30) . In agreement with the in situ data, (Fig.  2Bf) , COLXIV-A protein was detected at 24 hpf in the nascent median fin fold ( Fig. 6A and B) . The fin fold epithelium is an extension of the epidermis. As described above, COLXIV-A is only expressed in basal epidermal cells (see Fig.  4C ). COLXIV-A was also restricted to the basal epidermal layer in the MFF (Fig. 6A and C -the distal rim of the fin fold is not stained). At 72 hpf, COLXIV-A co-localized with laminin in the distal fin fold (Fig. 6C and D and data not shown). At this stage, the fin fold is pointed: it has proximally a thick base, and tapers off, becoming very thin distally. In a median optical section of the MFF, the connective tissue core is therefore visible proximally, and the BM is visible distally. COLXIV-A was at this stage not detected in the proximal fin fold, indicating that it was not expressed in the connective tissue core (Fig. 6C and D) . It was also not detected in the fin fold epithelium anymore (data not shown). In contrast, COLXII was not detected in the MFF at 24 hpf, and localized to the connective tissue core at 72 hpf (data not shown and (14)). Both collagens could be detected in the connective tissue beneath the MFF (Fig. 6C and D and (14) ). A similar staining pattern was observed in the apical fin fold of the pectoral bud, e.g. COLXIV-A was expressed in the epithelium of the nascent apical fold at 48 hpf, but was restricted to the BM at 72 hpf ( Fig. 6E and G) . In contrast, COLXII was not expressed in the apical fin fold at 48 hpf, and could be detected only within the connective tissue of the apical fin fold at 72 hpf ( Fig. 6F and H) . Taken together, the expression pattern of COLXIV-A suggests that it is involved in the morphogenesis and outgrowth of the median and apical fin fold.
COLXIV-A knockdown results in defects in BM structure, and impaired dermal cohesion
To analyze the function of COLXIV-A, we performed morpholino knockdown of COLXIV-A in developing embryos. One-cell stage embryos were thus injected with morpholinos targeted to the translational start site region (MO) or with 5-base mismatch control (MS). The specificity and efficiency of MO were checked by Western blot of total protein extracted from 24 and 48 hpf uninjected (Ctrl) and injected embryos (MO and MS) (Fig. 7A) . The two bands corresponding to the COLXIV-A strongly decreased in lysates of 24 and 48 hpf MO-injected embryos whereas they were unaffected in MS lysates as compared to uninjected embryos lysates. The gross morphology of MO-injected embryos at 24 and 48 hpf was normal when compared to MSinjected and uninjected embryos (Fig. 7B) . At the histological level, a detachment of the skin was observed in some areas (black arrowheads, Fig.  7C ). Importantly, this was not simply a fixation artifact, since it was consistently seen in MOinjected, but not MS injected embryos. In contrast, no defects were observed in the epidermis, or in other tissues and organs. It has to be noted that the skin detachment was also accompanied by the presence of apoptotic cells in the dermis (white arrowhead). This finding is in agreement with very recent results demonstrating high level of cardiac fibroblast cell death in the post-natal ventricular myocardium of Col14a1 -/-mouse (31). To gain a better understanding of the skin detachment phenotype, we next examined the skin with transmission electron microscopy (TEM). TEM revealed that MO-injected embryos had profound defects in the epidermaldermal BM structure. At 24 hpf, a BM was clearly visible in MS-injected embryos, consisting of an electron dense (lamina densa, Fig. 7D, 1 ) and electron lucent (lamina lucida, Fig. 7D, 2) zone. In addition, adepidermal granules (Fig. 7D, 3) were visible in the lamina lucida. In contrast, MO-injected embryos lacked a lamina lucida and lamina densa at 24 hpf, although some adepidermal granules could be detected close to the plasma membrane (Fig. 7D,  4) (Fig. 7D, compare upper right and left panel) . At 48 hpf, a well delineated lamina densa ( (Fig.  7D, bottom left panel) . In contrast, the lamina densa (Fig. 7D, 1 ) of MO-injected embryos had a fuzzy appearance (Fig. 7D, bottom right) . Furthermore, the lamina lucida (Fig. 7D, 2) was extremely thin in MO-injected embryos. Also, whereas the adepidermal granules (Fig. 7D, 3) were regularly spaced in the MS-injected embryos at 48 hpf, their distribution was uneven in the MO-injected embryos, with frequent gaps (Fig. 7D, compare bottom right and left panels) . Interestingly, fewer invaginations of the plasma membrane (Fig. 7D, 4) were observed in the MO-injected embryos at 48 hpf (Fig. 7D , compare bottom left and right panels), suggesting that MO-injected embryos may secrete less BM material. Taken together, these results show that the assembly of the BM is severely compromised in MO-injected embryos. Despite structural defects in the BM, we did not observe a split between the epidermis and the BM. However, we saw frequently ruptures in the dermis (Fig. 7D, upper right panel) . Hence, the detachment of the epidermis appeared to be caused by splits in the dermis. It is possible that tears in the dermis are caused by impaired cohesion of the dermis to the BM. Alternatively, the dysfunctional BM may lead to increased mechanical stress on the dermis, which in turn may cause the dermis to rupture.
7D, 1) was visible in MS-injected embryos
DISCUSSION
Collagens XII and XIV may have distinct spatio-temporal expression patterns during zebrafish development
Collagens XII and XIV are closely related members of a subset of the collagen family, the FACITs (1). Due to their similar structure and overlapping expression pattern, a central question has been whether these two collagens have redundant or distinct functions. Recently, the function of these related FACIT collagens has been in part elucidated by generating nullmouse lines for col12a1 (32) and col14a1 (9) genes, respectively. Whereas COLXIV is involved in the regulation of collagen fibrillogenesis in early development, COLXII displayed a more unexpected function in the control of osteoblast polarity during bone formation. However, possible redundancy of the two collagens has not yet been investigated in collagens XII/XIV null mouse lines. Our data show that collagens XII and XIV may have distinct spatio-temporal expression patterns during zebrafish development. COLXII is expressed throughout development in connective tissues (14) , whereas COLXIV-A is transiently expressed in epithelia at 24 hpf. Thus, COLXII appears to localize to connective tissues, and COLXIV-A to epithelia.
COLXIV-A persists in BMs at 48 and 72 hpf
Although COLXIV-A is absent from most epithelia at later time points (48 hpf -72 hpf), we could still detect it in BMs, where its expression overlapped with COLXII. BM components are generally made by epithelial cells. However, fibroblasts may synthesize components of the BM zone, the junction between BM and connective tissue. col14a1a transcripts were detected in the epidermis, cranial placodes and endodermal pouches at 24 hpf. However, with few exceptions, COLXIV-A could not be detected in either epithelial cells or fibroblasts at 48 -72 hpf. It is therefore unclear which of these cell types is the source of COLXIV-A detected in the BM at these developmental stages. Since collagens are often very stable, it is possible that COLXIV-A incorporated into the BM at 24 hpf persists at 48 and 72 hpf. This is supported by the observation that col14a1a transcripts are very low from 72 hpf onwards. However, it is also possible that col14a1a transcripts are simply below the detection level of ISH at 48 and 72 hpf.
COLXIV-A is expressed in undifferentiated epithelia
Our data indicate that COLXIV-A is specifically expressed in undifferentiated epithelia. Hence, expression in several epithelia was observed at 24 hpf, but not at 48/72 hpf. Previous work has established that COLXIV is a component of connective tissues. To our knowledge, we are the first to show that COLXIV is a genuine, albeit transient component of epithelia. Basal epithelial cells synthesize components of a provisional ECM during embryogenesis (33), as well as components of the BM. However, in the cranial placodes, COLXIV-A was not only present in basal epithelial cells, but throughout the entire epithelium. Furthermore, in basal epidermal cells, COLXIV-A did not show a polarized distribution; instead, it could be detected at both the apical and basal sides of the cells. This suggests that COLXIV-A synthesized by epithelial cells is not only deposited into the BM, by guest on November 19, 2017 http://www.jbc.org/ Downloaded from but also into the pericellular ECM. Based on its expression pattern, it is tempting to speculate that COLXIV-A plays a role in the cohesion of epithelia sheets and/or in the outgrowth of epithelial folds, such as the endodermal pouches and the median and apical fin folds. However, in the COLXIV-A knock-down, the cohesion of epithelial sheets was not compromised. Nevertheless, it is possible that epithelial defects did not manifest due to compensation by other ECM proteins.
In other species, COLXIV has not been detected in epithelia, except transiently in basal epidermal or ectodermal cells, suggesting possible differences between species. However, since expression pattern studies of COLXIV in tetrapods have been so far mostly restricted to late developmental stages, this discrepancy may reflect differences between the developmental stages analyzed, rather than differences between species. In addition, col14a1b may localize to connective tissues, as described for tetrapod COLXIV.
COLXIV-A is a component of BMs, and is needed for BM assembly
By immunofluorescence, we detected COLXIV-A in several BMs at 24 hpf -72 hpf, including the epidermal-dermal BM. Co-staining with laminin, and detection of the col14a1a transcripts in epithelia at 24 hpf further confirmed that COLXIV-A is a component of embryonic BMs in zebrafish. At 24 hpf, when the epidermis starts to differentiate, the BM is very thin, indicating that BM deposition has just begun (18, 33) . At this stage, COLXIV-A is highly expressed in epithelia, and can be also detected in the BM. COLXIV-A knock-down impaired the formation of the BM, suggesting that COLXIV-A is needed for the initiation of the BM. Although COLXIV binds to perlecan, a BM proteoglycan, COLXIV does neither bind to laminin nor COLIV (34), two scaffold forming BM proteins thought to initialize the assembly of the BM. Also, in contrast to other collagens, COLXIV does not form polymers. How COLXIV-A affects BM initiation is therefore presently unclear. Interestingly, at 48 hpf, BM assembly was still impaired, indicating that other proteins could not fully compensate for the absence of COLXIV-A. It is likely that defects in the BM structure underlie the skin detachment defect observed in the COLXIV-A knock-down.
However, in addition, COLXIV-A may also link the BM to the subjacent dermis, and impaired BM-dermis cohesion could contribute to the skin detachment phenotype. Collagen XIV binds to both the BM proteoglycan perlecan and dermal type I collagen fibrils (13, 35) , making it an ideal bridging protein. Furthermore, it was recently shown that in humans, COLXIV is present in anchoring plaques, e.g. protein complexes that link the dermis to the BM (13,35) .
Col14a1-null mice do not exhibit skin blistering and the formation of the epidermal-dermal BM is not obviously affected. However, interestingly, the skin of Col14a1-null mice shows decreased resistance to mechanical stress. In agreement with the predicted role of collagen XIV as an inhibitor of lateral fibril growth, Col14a1-null mice have thicker collagen fibrils in the tendon, which results in altered mechanical properties of the tendon in pups (e.g. reduced stress resistance). The altered mechanical properties of the skin could be therefore also due to defects in collagen fibrillogenesis. Since COLXIV is also a component of anchoring plaques, subtle defects in dermal-epidermal cohesion may also contribute to the decreased stress resistance of the skin of Col14a1-null mice. Our study shows that COLXIV has a role in BM formation, whereas Col14a1-null mice were shown to have defects in collagen fibrillogenesis. Clearly, differences between species -e.g. zebrafish and mouse, respectively -could explain these different findings. However, we believe that COLXIV may have different functions in early versus late development, and that the role of COLXIV in BM formation during embryogenesis may be conserved in tetrapods. In support of this, COLXIV has been detected in the BM of human fetus. Defects in BM formation may not become apparent in the Col14a1-mice due to compensation by other ECM proteins, or increased redundancy in the ECM of tetrapods. In support of this, COLXIV has been detected in the BM of human fetus (5) . Defects in BM formation may not become apparent in the Col14a1-null mice due to compensation by other ECM proteins, or increased redundancy in the ECM of tetrapods. The fact that COLXIV-A is expressed by undifferentiated, but not differentiated epithelia suggests that it could function as signaling molecule that maintains an undifferentiated, proliferative state. At later developmental stages, by guest on November 19, 2017 http://www.jbc.org/ Downloaded from the balance of BM proteins promoting or inhibiting differentiation could shift towards differentiation. However, no epithelial defects were observed in the COLXIV-A knock-down, suggesting that several ECM proteins may function in providing proliferative cues and inhibiting differentiation during early embryogenesis.
In conclusion, we show that COLXIV-A function is not restricted to the regulation of collagen fibril assembly. Our results revealed a previously unsuspected role of COLXIV-A in undifferentiated epithelia and in BM assembly. We propose that COLXIV may have stage specific roles in epithelia and connective tissues, respectively.
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Le and (f) were developed shorter than the embryo shown in (e) to reveal the staining in the head and the fin fold, which is otherwise obscured by the strong signal in the skin. At the 18 somites stage (a-c), the col14a1a specific probe stains the skin throughout the embryo and within the head (a), a band (arrow) between the telencephalon and the otic placode (b) and (c) the nascent median fin fold (ff). At 24 hpf (d-f), col14a1a mRNA is detected in the roof of the forebrain (arrowhead, d), the olfactory placode/nasal pit (np), the midbrain-hindbrain boundary and the pharyngeal pouches; expression in the skin (e) and in the median fin fold (f) is maintained. At 48 hpf (g-i), col14a1a mRNA is detected in the gill endoderm (h, small arrows) and the otic anterior macula (h, thick arrow), within the pectoral fin bud (g, i), in the apical fin fold/apical ectodermal ridge (detail, i). At 72 hpf (j-l), col14a1a is strongly expressed in the gut (j, arrowhead) and in the anterior macula (k, arrow), whereas expression within the pectoral fin bud has ceased (l). t, telencephalon; ff, fin fold; o, otic placode; mhb, midbrainhindbrain boundary; pp, pharyngeal pouches; aer, apical ectodermal ridge. 
